Publikace
- Effect of Alirocumab on Mortality After Acute Coronary Syndromes An Analysis of the ODYSSEY OUTCOMES Randomized Clinical Trial2019 | Publikace bez příslušnosti k fakultě
- Fluvastatin in the first-line therapy of acute coronary syndrome: results of the multicenter, randomized, double-blind, placebo-controlled trial (the FACS-trial)2010 | 2. lékařská fakulta
- Pregnancy-associated plasma protein A and proform eosinophilic major basic protein in the detection of different types of coronary artery disease2008 | 2. lékařská fakulta, 1. lékařská fakulta, Fakulta tělesné výchovy a sportu, Ústřední knihovna
- Fluvastatin in the therapy of acute coronary syndrome: Rationale and design of a multicenter, randomized, double-blind, placebo-controlled trial (The FACS Trial) [ISRCTN81331696]2005 | 2. lékařská fakulta, 1. lékařská fakulta, Fakulta tělesné výchovy a sportu
- The effect of early treatment by cerivastatin on the serum level of C-reactive protein, interleukin-6, and interleukin-8 in the patients with unstable angina and non-Q-wave myocardial infarction2003 | 2. lékařská fakulta, 1. lékařská fakulta, Fakulta tělesné výchovy a sportu
- Pregnancy-associated plasma protein a (PAPP-a) in determination of unstable coronary plaquePublikace bez příslušnosti k fakultě
- Predictors of long-term survival in patients treated with targeted temperature management after cardiac arrest2020 | Matematicko-fyzikální fakulta
- Effect of Alirocumab on Lipoprotein(a) and Cardiovascular Risk After Acute Coronary Syndrome2020 | Publikace bez příslušnosti k fakultě
- Peripheral Artery Disease and Venous Thromboembolic Events After Acute Coronary Syndrome Role of Lipoprotein(a) and Modification by Alirocumab: Prespecified Analysis of the ODYSSEY OUTCOMES Randomized Clinical Trial2020 | Publikace bez příslušnosti k fakultě
- Pitfalls of anticoagulation therapy in pregnant women with mechanical valve prostheses. The case of two thrombotic events during one pregnancy2019 | Publikace bez příslušnosti k fakultě
Loading network view...